Imbio RV/LV Software vs KardiaAI
AI Verdict
Choose Imbio RV/LV Software if…
Choose Imbio RV/LV Software if your primary need is rapid, automated risk stratification for pulmonary conditions, such as suspected pulmonary embolism, directly from CTPA scans. This tool is ideal for radiology and emergency departments requiring precise, AI-driven measurements of right and left ventricular diameters and their ratio to inform acute patient management.
View Imbio RV/LV Software →Choose KardiaAI if…
Choose KardiaAI if you require a robust, FDA-cleared AI engine for analyzing ambulatory ECG rhythms to detect a wide range of cardiac conditions like AFib, bradycardia, and tachycardia. This solution is best suited for integration into mobile health applications, wearable devices, or other ECG platforms where continuous or intermittent heart rhythm monitoring and automated interpretation are critical.
View KardiaAI →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio RV/LV Software | KardiaAI |
|---|---|---|
| Pricing | Unknown | Subscription-based for advanced features and services. |
| Deployment | Cloud-based, Locally virtualized (virtual machine, Docker), or through partners like Aidoc, Blackford Analysis, and Philips Healthcare. [9, 27] | Mobile app, cloud-based. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Imbio RV/LV SoftwareImbio RV/LV Software offers a fully automated workflow that integrates seamlessly into standard reading environments like PACS, requiring no user intervention after scan completion. This hands-off approach within existing clinical systems provides superior usability for radiologists. KardiaAI, as an API library, relies on the usability of the applications it's integrated into.
Clinical Value
TieBoth tools provide significant and validated clinical value. Imbio RV/LV Software offers critical, automated measurements for acute pulmonary embolism risk stratification. KardiaAI provides broad, accurate detection of various cardiac arrhythmias for both acute and chronic management. Their distinct applications make it difficult to declare one definitively superior in overall clinical value.
Pricing & Value
KardiaAIKardiaAI offers transparent and affordable consumer-facing subscription plans (KardiaCare) that directly leverage its AI, making medical-grade heart monitoring accessible to individuals. While both tools are subscription-based for enterprise use with non-public pricing, KardiaAI's clear value proposition for a segment of its users gives it an edge in pricing transparency and accessibility.
Enterprise Readiness
Imbio RV/LV SoftwareImbio RV/LV Software demonstrates robust enterprise readiness with flexible deployment options including cloud, on-premise (VMware solution), and integration with numerous established partner platforms like Nuance and Siemens Syngo.via. This breadth of deployment and integration capabilities is crucial for large healthcare systems. KardiaAI, while compliant and integratable via API, offers a more focused deployment model.
Innovation
KardiaAIKardiaAI, as part of the AliveCor ecosystem, revolutionized personal cardiac monitoring by bringing medical-grade ECG analysis and AI-driven arrhythmia detection directly to patients, significantly impacting healthcare delivery and accessibility. While Imbio's automation of RV/LV ratio is innovative for radiology workflows, KardiaAI's broader disruptive impact on patient engagement and remote diagnostics is arguably more transformative.
Support & Docs
KardiaAIAliveCor, through its direct-to-consumer products powered by KardiaAI, provides extensive and publicly accessible support resources, including FAQs, user manuals, and customer service contacts. While Imbio would offer enterprise-level support, the visible and comprehensive nature of KardiaAI's support and documentation for its end-users suggests a stronger, more transparent offering in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio RV/LV Software | KardiaAI |
|---|---|---|
| Name | Imbio RV/LV Software | KardiaAI |
| Company | Imbio | AliveCor |
| Description | AI-powered tool that automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism. | FDA-cleared AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions like AFib, bradycardia, and tachycardia. |
| Key Features | Automated measurement of right and left ventricular diameters; Calculation and reporting of RV/LV ratio; Artificial intelligence algorithm for ventricle identification and measurement; Provides annotated images showing ventricular measurements; Generates summary PDF reports; Fully automated workflow, no user intervention required after scan completion; DICOM compliant input and output; Integration with standard reading environments (PACS). | AI-powered ECG analysis library; Detection of atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm; Detection of Sinus Rhythm with Premature Ventricular Contractions (PVCs); Detection of Sinus Rhythm with Wide QRS; Detection of Sinus Rhythm with Supraventricular Ectopy (SVE); ECG noise filtering and noisy ECG detection; API library for integration into other ECG devices and software; Medical-grade accuracy for heart rhythm data. |
| Specialties | Cardiology, Pulmonology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Imbio RV/LV Software and KardiaAI.
Frequently Asked Questions
More Comparisons
More matchups featuring Imbio RV/LV Software or KardiaAI
Backers
Who funded each tool's parent company.